FDA Investigator Jennifer D Hollstrom
Jennifer D Hollstrom has inspections in 5 countries as of 13 Jul 2023. Jennifer D Hollstrom has collaborated with a combined 2920 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
13 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland,
United States of America,
Ireland,
Canada,
Italy
Co-Investigator(s):
Aaron P Wozniak,
Adalberto Cajigas,
Adam R Cooke,
Ademola O Daramola,
Amy H Ruble,
Ana Delp Cintron,
Ana P Barido,
Anthony Abel,
Ashar P Parikh,
Azza Talaat,
Barbara Jwilimczyk Macri,
Barbara M Frazier,
Billy M Battles,
Brittny C Cargo,
Carl A Anderson,
Carlos M Gonzalez,
CDR Ileana Barreto Pettit,
CDR Thomas R Berry, PPh,
Cherrie A Zachary,
Cheryl A Clausen,
Chiaochun J Wang,
Christian D Lynch (CDL),
Claire M Minden,
Craig A Garmendia,
Cynthia Jim, CSO,
Dandan Wang, PhD,
Daryl A Dewoskin,
Dawn M Mccabe,
Dennis Cantellops Paite,
Devaughn Edwards,
Deyaa Shaheen,
Dillard H Woody, Jr,
Donald C Obenhuber, PhD,
Donna Mwilliams Hill,
Douglas C Kovacs,
Dr. Carmelo Rosa,
Dyvette Arline,
Eileen J Bannerman,
Elizabeth Ll Edwards,
Erika V Butler,
Erin C Hill,
Erin D Mccaffery,
Fabian Nchaparro Rodriguez,
Farhana Khan,
Gabriel R Mclemore,
George J Flynn,
Gerald B Seaborn, Jr,
Geraldine D Sanders,
Gideon N Esuzor,
Hai L Phung,
Hai Lien T Phung,
Hector A Carrero,
Ibad U Khan,
Jacqueline Mdiaz Albertini,
James A Lane,
James I Giefer,
Janet L Bowen,
Janis R Armedoriz,
Jared P Stevens,
Jason F Chancey,
Jawaid Hamid,
Jeffrey A Sommers,
Jennifer L Huntington,
Jennifer Lalama,
Jennifer M Menendez,
Jessica L Pressley,
Joanne E King,
Jocelyn E Massey,
Joey V Quitania,
Jogy George,
Jolanna A Norton,
Jose Acruz Gonzalez,
Jose E Melendez, DDC,
Jose M Cayuela,
Joseph F Owens,
Karen G Hirshfield,
Kathleen D Culver,
Kelvin Cheung,
Kenneth V Miller,
Kim Lthomas Cruse,
Larry K Hampton,
Lawrence Carter, III,
LCDR Debra Emerson,
LCDR Michael H Tollon,
Libia M Lugo,
LT Daveta L Bailey,
LT Tamara J Henderson,
Luis A Carrion,
Margaret L Bolte,
Maria V Price,
Marie F Morin,
Marvin D Jones,
Mary Jeanet Mcgarry,
Matthew B Casale,
Matthew R Dionne,
Melanie M Walker,
Michael L Casner,
Michael P Sheehan,
Michael R Goga,
Michael R Klapal,
Michele L Forster, PhD,
Michele L Obert,
Michelle Y Clark Stuart,
Miguel A Martinez,
Mihaly S Ligmond,
Mindy M Chou,
Monica Cburgos Garcia,
Mra Davism,
Mra Mcculloughj,
Nancy G Schmidt,
Niketa Patel,
Noreen Muniz,
Omotunde O Osunsanmi,
Patricia H Dlugosz,
Paul L Figarole, Jr,
Penny H Mccarver,
Perry H Gambrell,
Prabhu P Raju,
Randy L Clarida,
Rebecca Rodriguez,
Renee S Blosser,
Rhonda Alexander,
Robert C Coleman,
Robert D Tollefsen,
Robert M Tillman,
Roger F Zabinski,
Rose M Ashley,
Roy R Rinc,
Rozelle G Smith,
Russell J Glapion,
Salvatore N Randazzo,
Sandra A Hughes,
Sangeeta M Khurana, PhD,
Santos E Camara,
Sarah E Mcmullen,
Satheesh Thomas,
Seneca D Toms,
Sharon K Thoma, PharmD,
Stephanie D Crockett,
Steve Y Rhieu, PhD,
Susan F Laska, MS,
Susan M Corrales,
Susan M Turcovski,
Susan P Bruederle,
Tamika D Cathey,
Tammara A Stephens,
Thomas E Friel,
Thomas J Arista,
Thomas R Withers,
Tonya R Johnson,
Torrance J Slayton,
Tracy R Ball,
Truong Xuan Nguyen (Andy),
Vicky C Stoakes,
Virginia L Meeks,
Viviana Matta,
Xiujing L Baggett,
Yong Hu,
Yuesheng Ye,
Yun Wu, PhD,
Zhong Li, PhD
Jennifer D Hollstrom's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2007 | EIR | JMI Daniels Pharmaceuticals, Inc - EIR, 2007-09-21 |
September, 2006 | EIR | Novo Nordisk Pharmaceutical Industries, LP - EIR, 2006-09-22 |
July, 2005 | EIR | Patheon Manufacturing Services LLC - EIR, 2005-07-29 |
April, 2006 | FDA 483 | Actavis Laboratories FL, Inc. - Form 483, 2006-04-18 |
April, 2008 | FDA 483 | Actavis Laboratories FL, Inc. - Form 483, 2008-04-10 |
September, 2007 | FDA 483 | JMI Daniels Pharmaceuticals, Inc - Form 483, 2007-09-21 |
September, 2006 | FDA 483 Response | Novo Nordisk Pharmaceutical Industries, LP - Form 483R, 2006-10-09 |
March, 2007 | FDA 483 Response | Leiner Health Product, Llc - Form 483R, 2007-04-09 |
October, 2005 | FDA 483 | Newco Pharm LLC - Form 483, 2005-10-12 |
March, 2007 | FDA 483 | Leiner Health Product, Llc - Form 483, 2007-03-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more